title: Reversible cutaneous side effects of vismodegib treatment.
authors.affiliation: Department of Dermatology, Stanford University School of Medicine, California, USA.
authors.forename: Bernice
authors.initials: B
authors.lastname: Kwong
authors.affiliation: Department of Dermatology, Stanford University School of Medicine, California, USA.
authors.forename: Christina
authors.initials: C
authors.lastname: Danial
authors.affiliation: Albert Einstein College of Medicine, Bronx, New York, USA.
authors.forename: Andy
authors.initials: A
authors.lastname: Liu
authors.affiliation: Virginia Commonwealth University School of Medicine, Richmond, USA.
authors.forename: Kimberly A
authors.initials: KA
authors.lastname: Chun
authors.affiliation: Department of Dermatology, Stanford University School of Medicine, California, USA.
authors.forename: Anne Lynn S
authors.initials: AL
authors.lastname: Chang
mesh_terms: D000505:Alopecia / Q000139:chemically induced / Q000175:diagnosis*; D000813:Anilides / Q000009:adverse effects* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000813:Anilides; D000970:Antineoplastic Agents; C538724:HhAntag691; D011725:Pyridines